Original ContributionBioelectrical impedance analysis for heart failure diagnosis in the ED

IntroductionThe aim of this study was to evaluate bioimpedance vector analysis (BIVA) for the diagnosis of acute heart failure (AHF) in patients presenting with acute dyspnea to the emergency department (ED).MethodsPatients with acute dyspnea presenting to the ED were prospectively enrolled. Four parameters were assessed: resistance (R), reactance (Ra), total body water (TBW), and extracellular body water (EBW). Brain natriuretic peptide (BNP) measures and cardiac ultrasound studies were performed in all patients at admission. Patients were classified into AHF and non-AHF groups retrospectively by expert cardiologists.ResultsSeventy-seven patients (39 men; age, 68 ± 14 years; weight, 79.8 ± 20.6 kg) were included. Of the 4 BIVA parameters, Ra was significantly lower in the AHF compared to non-AHF group (32.7 ± 14.3 vs 45.4 ± 19.7; P < .001). Brain natriuretic peptide levels were significantly higher in the AHF group (1050.3 ± 989 vs 148.7 ± 181.1 ng/L; P < .001). Reactance levels were significantly correlated to BNP levels (r = − 0.5; P < .001). Patients with different mitral valve Doppler profiles (E/e' ≤ 8, E/e' ≥ 9 and < 15, and E/e' ≥ 15) had significant differences in Ra values (47.9 ± 19.9, 34.7 ± 19.4, and 31.2 ± 11.7, respectively; P = .003). Overall, the sensitivity of BIVA for AHF diagnosis with a Ra cutoff at 39 Ω was 67% with a specificity of 76% and an area under the curve at 0.76. However, Ra did not significantly improve the area under the curve of BNP for the diagnosis of AHF (P = not significant).ConclusionIn a population of patients presenting to the ED with dyspnea, BIVA was significantly related to the AHF status but did not improve the diagnostic performance for AHF in addition to BNP alone.